A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice
Clinical trial NCT05069545 · COMPLETED
Trial details
- NCT number
- NCT05069545
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-10-11
- Primary completion
- 2024-09-10
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.